Nordic Innovation Spotlight: Aarhus-Harvard's Oxygen Therapy Breakthrough

In a notable development for the Nordic tech scene, the National Institute of Health (NIH) in the US has awarded a significant grant of DKK 14 million to a pioneering Danish-American research collaboration. Led by Dr. Mads Dam Lyhne from Aarhus University Hospital, the team is gearing up to delve into the therapeutic potentials of oxygen for acute pulmonary embolisms.

Having already made strides with Harvard Medical School and Massachusetts General Hospital, the Aarhus team's research zeroes in on using oxygen to treat acute lung blood clots. These clots can dangerously spike blood pressure, leading to life-threatening conditions like acute heart failure.

Dr. Lyhne's groundbreaking PhD work, which showcased the efficacy of oxygen therapy in reducing lung blood pressure using pigs as a model, serves as the cornerstone of this initiative. With the newfound funding and collaboration, the research is poised to further explore oxygen therapy's impact on patients and the science behind its benefits. The Nordic tech scene eagerly awaits the insights from this four-year project, spotlighting the region's commitment to global health advancements.